Invivoscribe introduced PrepQuant, an integrated sample preparation platform designed to standardize nucleic-acid extraction, concentration, and quantification in a single automated instrument. The assay-agnostic system is meant to reduce pre-analytical variability and labor across NGS, qPCR, and digital PCR workflows, and was developed in collaboration with Hitachi High-Tech. PrepQuant is validated for blood, plasma, and bone marrow specimens.